Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome

Abstract

The continuous administration of aerosolized synthetic surfactant to patients with sepsis-induced ARDS had no significant effect on 30-day survival, length of stay in the intensive care unit, duration of mechanical ventilation, or physiologic function.